Legend Biotech CEO Ingrid Zhang reports purchase of $163,200 in common shares
LEGN•Legend Biotech CEO Ingrid Zhang purchased 20,000 ordinary shares at $8.16 each, increasing her direct beneficial ownership to 1,151,860 shares.
LEGN•Legend Biotech CEO Ingrid Zhang purchased 20,000 ordinary shares at $8.16 each, increasing her direct beneficial ownership to 1,151,860 shares.
Ingrid Zhang, chief executive officer of Legend Biotech, purchased 20,000 ordinary shares at $8.16 per share. Her direct beneficial ownership rose to 1,151,860 ordinary shares.